Brad Haller is a senior partner in West Monroe Partners’ Mergers & Acquisitions practice, leading the firm’s extensive capabilities in post-merger integration. A trusted advisor to many private equity firms and strategic buyers, he has led more than 500 M&A transactions in the last decade.
Brad can speak to dealmaking, deals, M&A, mergers, acquisitions, acquisition, private equity, PE, portfolio companies, portcos, diligence, tech diligence, value creation, antitrust, DOJ, Department of Justice, transactions, takeovers, and more.
Looking at Warner Bros. Discovery’s portfolio, CNN seems like the most noncore asset — and if a company is looking to pay down debt that’s where it often looks first for a sale.
Given the horsepower that the DOJ is throwing at this, like they're looking for something concrete to be done, or I don't think they would settle for a settlement.
The Cigna-Express Scripts deal is essentially a replication of what UnitedHealth has done. The government doesn’t want to be negotiating with someone of that scale in Medicare.
Middle Market Growth's Middle Market DealMaker Summer 2022 edition explores M&A in the oil and gas sector amid industry volatility
The U.S. software company calls Cerner an “anchor asset” for its healthcare ambitions.
New federal guidelines aimed at clamping down on antitrust violations are likely to prolong a slump in venture-backed startup acquisitions, which have slowed to a crawl amid higher interest rates and unsteady market conditions.